(D) Immunoblots of pYAP (S127) and YAP/TAZ in indicated EGFR-mutant NSCLC cell lines treated with DMSO or 1 μM EGFR-TKI (Erlotinib, except EGF816 for NCI-H1975) for 24 hr. Here, EGFR is linked to non-small cell lung carcinoma.